Management tracks

Digital health company Adherium Ltd. (ASX:ADR) named Thomas Lynch chairman and said board member Doug Wilson will step down and transition to a part-time role as executive medical director. Lynch also is chairman of Evofem Inc. (San Diego, Calif.) and Profectus BioSciences Inc. (Baltimore, Md.), and a director at GW Pharmaceuticals plc (LSE:GWP; NASDAQ:GWPH).

Cancer and drug delivery company Halozyme Therapeutics Inc. (NASDAQ:HALO) hired Mark Gergen as SVP and COO. He previously was EVP and COO at Mirati Therapeutics Inc. (NASDAQ:MRTX). ...